Companies / BOC Sciences / Bexmarilimab
BOC Sciences

Bexmarilimab | BOC Sciences

Bexmarilimab is a humanized monoclonal antibody against Clever-1, a macrophage scavenger receptor known to induce intratumoural immunosuppression. Bexmarilimab has been investigated for the treatment of solid tumors.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.